|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng Y, Zhang X, Ma Q, Yan R, Qin Y, Zhao
Y, Cheng Y, Yang M, Wang Q, Feng X, et al: MiRNA-194 activates the
Wnt/β-catenin signaling pathway in gastric cancer by targeting the
negative Wnt regulator, SUFU. Cancer Lett. 385:117–127. 2017.
View Article : Google Scholar
|
|
6
|
Luo H and Liang C: MicroRNA-148b inhibits
proliferation and the epithelial-mesenchymal transition and
increases radiosensi-tivity in non-small cell lung carcinomas by
regulating ROCK1. Exp Ther Med. 15:3609–3616. 2018.PubMed/NCBI
|
|
7
|
Gruszka R and Zakrzewska M: The oncogenic
relevance of miR-17-92 cluster and its paralogous miR-106b-25 and
miR-106a-363 clusters in brain tumors. Int J Mol Sci.
19:192018.
|
|
8
|
Inoue A, Mizushima T, Wu X, Okuzaki D,
Kambara N, Ishikawa S, Wang J, Qian Y, Hirose H, Yokoyama Y, et al:
A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive
Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon
Cancer Cells. Mol Cancer Ther. 17:977–987. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murray-Stewart T, Sierra JC, Piazuelo MB,
Mera RM, Chaturvedi R, Bravo LE, Correa P, Schneider BG, Wilson KT
and Casero RA: Epigenetic silencing of miR-124 prevents spermine
oxidase regulation: Implications for Helicobacter pylori-induced
gastric cancer. Oncogene. 35:5480–5488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao Y, Tan S, Tu Y, Zhang G, Liu Y, Li D,
Xu S, Le Z, Xiong J, Zou W, et al: MicroRNA-125a-5p inhibits
invasion and metastasis of gastric cancer cells by targeting BRMS1
expression. Oncol Lett. 15:5119–5130. 2018.PubMed/NCBI
|
|
12
|
Yu X, Ma C, Fu L, Dong J and Ying J:
MicroRNA-139 inhibits the proliferation, migration and invasion of
gastric cancer cells by directly targeting ρ-associated protein
kinase 1. Oncol Lett. 15:5977–5982. 2018.PubMed/NCBI
|
|
13
|
Hu L, Wu H, Wan X, Liu L, He Y, Zhu L, Liu
S, Yao H and Zhu Z: MicroRNA-585 suppresses tumor proliferation and
migration in gastric cancer by directly targeting MAPK1. Biochem
Biophys Res Commun. 499:52–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan C, Yu J, Liu Y, Kang W, Ma Z and Zhou
L: MiR-32 promotes gastric carcinoma tumorigenesis by targeting
Kruppel-like factor 4. Biochem Biophys Res Commun. 467:913–920.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Delaunoit T: Latest developments and
emerging treatment options in the management of stomach cancer.
Cancer Manag Res. 3:257–266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SG, Kim K, Kegelman TP, Dash R, Das
SK, Choi JK, Emdad L, Howlett EL, Jeon HY, Su ZZ, et al: Oncogene
AEG-1 promotes glioma-induced neurodegeneration by increasing
glutamate excitotoxicity. Cancer Res. 71:6514–6523. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park SY, Choi M, Park D, Jeong M, Ahn KS,
Lee J, Fisher PB, Yun M and Lee SG: AEG-1 promotes mesenchymal
transition through the activation of Rho GTPases in human
glioblastoma cells. Oncol Rep. 36:2641–2646. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang Y, Hu J, Li J, Liu Y, Yu J, Zhuang
X, Mu L, Kong X, Hong D, Yang Q, et al: Epigenetic Activation of
TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast
Cancer. Cancer Res. 75:3672–3680. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu G, Chong RA, Yang Q, Wei Y, Blanco MA,
Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22
genomic gain promotes chemoresistance and metastasis of
poor-prognosis breast cancer. Cancer Cell. 15:9–20. 2009.
View Article : Google Scholar :
|
|
21
|
Robertson CL, Srivastava J, Siddiq A,
Gredler R, Emdad L, Rajasekaran D, Akiel M, Shen XN, Guo C,
Giashuddin S, et al: Genetic deletion of AEG-1 prevents
hepatocarcinogenesis. Cancer Res. 74:6184–6193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Srivastava J, Siddiq A, Emdad L,
Santhekadur PK, Chen D, Gredler R, Shen XN, Robertson CL, Dumur CI,
Hylemon PB, et al: Astrocyte elevated gene-1 promotes
hepatocarcinogenesis: Novel insights from a mouse model.
Hepatology. 56:1782–1791. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li G, Wang Z, Ye J, Zhang X, Wu H, Peng J,
Song W, Chen C, Cai S, He Y, et al: Uncontrolled inflammation
induced by AEG-1 promotes gastric cancer and poor prognosis. Cancer
Res. 74:5541–5552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu H, Song X, Liu C, Xie L, Wei L and Sun
R: Knockdown of astrocyte elevated gene-1 inhibits proliferation
and enhancing chemo-sensitivity to cisplatin or doxorubicin in
neuroblastoma cells. J Exp Clin Cancer Res. 28:192009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dicken BJ, Bigam DL, Cass C, Mackey JR,
Joy AA and Hamilton SM: Gastric adenocarcinoma: Review and
considerations for future directions. Ann Surg. 241:27–39.
2005.
|
|
26
|
Ikoma N, Blum M, Estrella JS, Das P,
Hofstetter WL, Fournier KF, Mansfield P, Ajani JA and Badgwell BD:
Evaluation of the American Joint Committee on Cancer 8th edition
staging system for gastric cancer patients after preoperative
therapy. Gastric Cancer. 21:74–83. 2018. View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43(D1): D146–D152. 2015. View Article : Google Scholar :
|
|
30
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
eLife. 4:42015. View Article : Google Scholar
|
|
31
|
Hu Y, Yu K, Wang G, Zhang D, Shi C, Ding
Y, Hong D, Zhang D, He H, Sun L, et al: Lanatoside C inhibits cell
proliferation and induces apoptosis through attenuating
Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell.
Biochem Pharmacol. 150:280–292. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar
|
|
33
|
Van Cutsem E, Dicato M, Geva R, Arber N,
Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M,
Glynne-Jones R, et al: The diagnosis and management of gastric
cancer: expert discussion and recommendations from the 12th
ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.
Ann Oncol. 22(Suppl 5): v1–v9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He G and Karin M: NF-κB and STAT3 - key
players in liver inflammation and cancer. Cell Res. 21:159–168.
2011. View Article : Google Scholar
|
|
35
|
Ghosh S and Karin M: Missing pieces in the
NF-kappaB puzzle. Cell. 109(Suppl): S81–S96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zandi E, Rothwarf DM, Delhase M, Hayakawa
M and Karin M: The IkappaB kinase complex (IKK) contains two kinase
subunits, IKKalpha and IKKbeta, necessary for IkappaB
phosphorylation and NF-kappaB activation. Cell. 91:243–252. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Grivennikov S, Karin E, Terzic J, Mucida
D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H,
Eckmann L, et al: IL-6 and Stat3 are required for survival of
intestinal epithelial cells and development of colitis-associated
cancer. Cancer Cell. 15:103–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He G, Yu GY, Temkin V, Ogata H, Kuntzen C,
Sakurai T, Sieghart W, Peck-Radosavljevic M, Leffert HL and Karin
M: Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and
progression by preventing oxidative stress-driven STAT3 activation.
Cancer Cell. 17:286–297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jin R, Yi Y, Yull FE, Blackwell TS, Clark
PE, Koyama T, Smith JA Jr and Matusik RJ: NF-κB gene signature
predicts prostate cancer progression. Cancer Res. 74:2763–2772.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Todoric J, Antonucci L, Di Caro G, Li N,
Wu X, Lytle NK, Dhar D, Banerjee S, Fagman JB, Browne CD, et al:
Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression
in Pancreas. Cancer Cell. 32:824–839.e8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen W, Li Z, Bai L and Lin Y: NF-kappaB
in lung cancer, a carcinogenesis mediator and a prevention and
therapy target. Front Biosci. 16:1172–1185. 2011. View Article : Google Scholar :
|
|
43
|
Karin M: NF-kappaB as a critical link
between inflammation and cancer. Cold Spring Harb Perspect Biol.
1:a0001412009. View Article : Google Scholar
|
|
44
|
Krishnan RK, Nolte H, Sun T, Kaur H,
Sreenivasan K, Looso M, Offermanns S, Krüger M and Swiercz JM:
Quantitative analysis of the TNF-α-induced phosphoproteome reveals
AEG-1/MTDH/LYRIC as an IKKβ substrate. Nat Commun. 6:66582015.
View Article : Google Scholar
|
|
45
|
Emdad L, Sarkar D, Su ZZ, Randolph A,
Boukerche H, Valerie K and Fisher PB: Activation of the nuclear
factor kappaB pathway by astrocyte elevated gene-1: Implications
for tumor progression and metastasis. Cancer Res. 66:1509–1516.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jiao X, Lu HJ, Zhai MM, Tan ZJ, Zhi HN,
Liu XM, Liu CH and Zhang DP: Overexpression of kallikrein gene 10
is a biomarker for predicting poor prognosis in gastric cancer.
World J Gastroenterol. 19:9425–9431. 2013. View Article : Google Scholar
|
|
47
|
Deng JY and Liang H: Clinical significance
of lymph node metastasis in gastric cancer. World J Gastroenterol.
20:3967–3975. 2014. View Article : Google Scholar : PubMed/NCBI
|
